Protocol for human placental mesenchymal stem cell therapy in a murine model of intra-abdominal infection of hypervirulent Klebsiella

Li Tzu Wang, Sheng Kang Chiu, Wei Lee, L. Kristopher Siu, Ko Jiunn Liu, Men Luh Yen, B. Linju Yen

Research output: Contribution to journalArticlepeer-review

Abstract

Hypervirulent Klebsiella pneumoniae (hvKP) strains cause extra-pulmonary infections such as intra-abdominal infection (IAI) even in healthy individuals due to its resistance to polymorphonuclear neutrophil (PMN) killing and a high incidence of multidrug resistance. To assess whether human placental mesenchymal stem cell (PMSC) therapy can be an effective treatment option, we established a murine model of hvKP-IAI to evaluate immune cell modulation and bacterial clearance for this highly lethal infection. This protocol can rapidly assess potential therapies for severe bacterial IAIs. For complete details on the use and execution of this protocol, please refer to Wang et al. (2020).

Original languageEnglish
Article number100337
JournalSTAR Protocols
Volume2
Issue number1
DOIs
Publication statusPublished - Mar 19 2021
Externally publishedYes

Keywords

  • Flow cytometry/mass cytometry
  • Immunology
  • Model organisms
  • Stem cells

ASJC Scopus subject areas

  • General Neuroscience
  • General Biochemistry,Genetics and Molecular Biology
  • General Immunology and Microbiology

Fingerprint

Dive into the research topics of 'Protocol for human placental mesenchymal stem cell therapy in a murine model of intra-abdominal infection of hypervirulent Klebsiella'. Together they form a unique fingerprint.

Cite this